Tag: Inari

Inari Medical Announces First Patient Enrolled in FLAME Study

IRVINE, Calif., April 05, 2021 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the enrollment of the first high-risk pulmonary embolism (“PE”) patient in the FlowTriever […]

Inari Medical Reports Preliminary Fourth Quarter 2020 Revenue

IRVINE, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Inari Medical Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported preliminary unaudited fourth quarter 2020 revenue. Preliminary Fourth Quarter Revenue and Business Highlights: Preliminary unaudited […]

Inari Medical Announces Presentation of Positive Results from First Patients in Real World FLASH Registry

IRVINE, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced positive results of the first 230 patients enrolled in its FLASH study. Interim […]

Inari Medical Appoints Cynthia Lucchese and Catherine Szyman to the Company’s Board of Directors

IRVINE, Calif., Jan. 28, 2020 /PRNewswire/ — Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced the appointment of Cynthia Lucchese and Catherine Szyman to the company’s Board of Directors. “We are pleased to welcome Cindy and Katie as new […]

Inari Medical Announces Publication of FLARE IDE Study Results

IRVINE, Calif., May 7, 2019 /PRNewswire/ — Inari Medical, Inc. announced today the publication of its 106-patient prospective multicenter FlowTriever Mechanical Pulmonary Embolectomy (FLARE) study for the treatment of intermediate-risk pulmonary embolism (PE).  The study was published in JACC: Cardiovascular Interventions.  FLARE was conducted under the direction of co-principal investigators, Dr. Kenneth Rosenfield, Section Head […]

Inari Medical Announces First Patient Enrolled in FLASH Registry Using the FlowTriever System for Pulmonary Embolism

IRVINE, Calif., Dec. 6, 2018 /PRNewswire/ — Inari Medical, Inc. announced today the enrollment of the first patient in the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (“FLASH”) using the FlowTriever® System for the treatment of pulmonary embolism (PE). FLASH is a 500-patient prospective, multicenter registry study to evaluate real world outcomes […]

Inari Medical Announces First Patient Enrolled in CLOUT Registry Using the ClotTriever Thrombectomy System

IRVINE, CALIFORNIA – September 27, 2018 — Inari Medical, Inc. announced today the enrollment of the first patient in the ClotTriever Outcomes Registry (“CLOUT”) using the ClotTriever® Thrombectomy System. CLOUT is a 500-patient prospective, multicenter, single-arm registry to evaluate real world outcomes after treatment of patients with thrombosis in the […]

FlowTriever System from Inari Medical Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism

IRVINE, Calif., May 21, 2018 /PRNewswire/ — Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism (“PE”). This clearance makes the FlowTriever System the first and only thrombectomy device cleared by the FDA for the treatment of PE.   The PE-specific clearance was based […]